{"id":"https://openalex.org/W2046196232","doi":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","title":"ELICITING PREFERENCES FOR DRUG TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA","display_name":"ELICITING PREFERENCES FOR DRUG TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-10","ids":{"openalex":"https://openalex.org/W2046196232","doi":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","mag":"2046196232","pmid":"https://pubmed.ncbi.nlm.nih.gov/15538258"},"language":"en","primary_location":{"id":"doi:10.1097/01.ju.0000140957.31325.7f","doi":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2046196232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041826068","display_name":"Verity Watson","orcid":"https://orcid.org/0000-0002-3824-5076","observed_orcids":["https://orcid.org/0000-0002-3824-5076"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. WATSON","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056075631","display_name":"M Ryan","orcid":"https://orcid.org/0000-0002-0083-772X","observed_orcids":["https://orcid.org/0000-0002-0083-772X"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. RYAN","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109310769","display_name":"C. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C.T. BROWN","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111489275","display_name":"Gillian Barnett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. BARNETT","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B.W. ELLIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B.W. ELLIS","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083172675","display_name":"Mark Emberton","orcid":"https://orcid.org/0000-0003-4230-0338","observed_orcids":["https://orcid.org/0000-0003-4230-0338"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. EMBERTON","raw_affiliation_strings":["From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom","institution_ids":["https://openalex.org/I195460627"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I195460627"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":2.4663,"has_fulltext":false,"cited_by_count":77,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87445687,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"172","issue":"6 Part 1","first_page":"2321","last_page":"2325"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.03920000046491623,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/lower-urinary-tract-symptoms","display_name":"lower urinary tract symptoms","score":0.9990000128746033},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.6610000133514404},{"id":"https://openalex.org/keywords/dutasteride","display_name":"dutasteride","score":0.8539999723434448},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibitors","display_name":"5-alpha reductase inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/alpha-blockers","display_name":"alpha-blockers","score":0.9980000257492065},{"id":"https://openalex.org/keywords/willingness-to-pay","display_name":"willingness to pay","score":0.656000018119812},{"id":"https://openalex.org/keywords/attribute-trade-offs","display_name":"attribute trade-offs","score":0.6890000104904175},{"id":"https://openalex.org/keywords/sexual-side-effects","display_name":"sexual side effects","score":0.8799999952316284},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/acute-urinary-retention","display_name":"acute urinary retention","score":0.9570000171661377},{"id":"https://openalex.org/keywords/prostate-size-reduction","display_name":"prostate size reduction","score":0.6899999976158142},{"id":"https://openalex.org/keywords/shared-decision-making","display_name":"shared decision-making","score":0.8130000233650208},{"id":"https://openalex.org/keywords/discrete-choice-experiment","display_name":"discrete choice experiment","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2779478474","wikidata":"https://www.wikidata.org/wiki/Q446372","display_name":"Lower urinary tract symptoms","level":4,"score":0.870417594909668},{"id":"https://openalex.org/C2778878792","wikidata":"https://www.wikidata.org/wiki/Q424760","display_name":"Dutasteride","level":4,"score":0.868859052658081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8553644418716431},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.58784419298172},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.5811935067176819},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4705023467540741},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4663754105567932},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.45400121808052063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43089044094085693},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068538","descriptor_name":"Dutasteride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077409","descriptor_name":"Tamsulosin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014555","descriptor_name":"Urination Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014555","descriptor_name":"Urination Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017292","descriptor_name":"Doxazosin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.ju.0000140957.31325.7f","doi":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000140957.31325.7f","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},{"id":"pmid:15538258","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15538258","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of urology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:158250","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/158250/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Urology , 172 pp. 2321-2325. (2004)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W84181955","https://openalex.org/W1964212813","https://openalex.org/W1966674905","https://openalex.org/W2030698665","https://openalex.org/W2051592657","https://openalex.org/W2070883023","https://openalex.org/W2091570324","https://openalex.org/W2126104986","https://openalex.org/W2135421268","https://openalex.org/W2144563350","https://openalex.org/W2178030545","https://openalex.org/W4296577666"],"related_works":["https://openalex.org/W2008070798","https://openalex.org/W4250615030","https://openalex.org/W2043106394","https://openalex.org/W2049835325","https://openalex.org/W2144927639","https://openalex.org/W2790785354","https://openalex.org/W2405872644","https://openalex.org/W2997647692","https://openalex.org/W1801847806","https://openalex.org/W2006716815"],"abstract_inverted_index":{"PURPOSE:":[0],"There":[1],"are":[2,130],"2":[3,180],"main":[4],"medical":[5,235],"preparations":[6],"available":[7],"for":[8,142,185,190],"lower":[9],"urinary":[10,107],"tract":[11],"symptoms":[12,205],"resulting":[13],"from":[14,80],"benign":[15],"prostatic":[16],"hyperplasia":[17],"(BPH).":[18],"Choosing":[19],"between":[20,29,42,134],"an":[21],"alpha-blocker":[22],"and":[23,40,50,99,110,113,137,172,181,194,199,217],"a":[24,57],"5alpha-reductase":[25,47,243],"inhibitor":[26,48,244],"requires":[27],"trade-offs":[28,41,127],"their":[30],"attributes":[31,44,136,149],"or":[32],"characteristics.":[33],"We":[34],"investigated":[35,87],"the":[36,43,46,81,89,103,120,126,138,195,218,230,242,248,259,263],"relative":[37,121],"importance":[38,122,260],"of":[39,45,105,123,197,220,233,250,261,265],"dutasteride":[49],"alpha-blockers":[51],"in":[52,88,188],"community":[53,238],"dwelling":[54,239],"men":[55,71,129,224,240],"using":[56],"validated":[58],"technique.":[59],"MATERIALS":[60],"AND":[61],"METHODS:":[62],"A":[63],"discrete":[64,90],"choice":[65,91],"experiment":[66,92],"was":[67,158,166],"administered":[68],"to":[69,95,132,140,152,177,214,257],"211":[70],"older":[72],"than":[73],"40":[74],"years":[75],"who":[76],"were":[77,93,145,150,175,206],"randomly":[78],"selected":[79],"general":[82],"United":[83],"Kingdom":[84],"population.":[85],"Attributes":[86],"time":[94,213],"symptom":[96,186,215],"improvement,":[97],"sexual":[98,210],"nonsexual":[100],"side":[101,159,164,211],"effects,":[102,212],"risks":[104,196],"acute":[106],"retention":[108],"(AUR)":[109],"surgery,":[111,200],"cost":[112],"prostate":[114,192],"size":[115],"decrease.":[116],"Using":[117],"regression":[118],"analysis":[119],"these":[124,135],"attributes,":[125],"that":[128],"willing":[131,176],"make":[133],"willingness":[139],"pay":[141],"each":[143],"attribute":[144,157,231],"estimated.":[146],"RESULTS:":[147],"All":[148],"important":[151,156,256],"respondents.":[153],"The":[154,161],"most":[155],"effects.":[160],"least":[162],"preferred":[163,241],"effects":[165],"impotence,":[167],"followed":[168],"by":[169],"decreased":[170,191],"libido":[171],"dizziness.":[173],"Respondents":[174],"wait":[178],"13,":[179],"8":[182],"months":[183],"longer":[184],"improvement":[187,216],"exchange":[189],"size,":[193],"AUR":[198,221],"respectively.":[201],"Men":[202],"reporting":[203,225],"moderate":[204],"less":[207],"concerned":[208],"about":[209],"risk":[219],"compared":[222],"with":[223,267],"mild":[226],"symptoms.":[227],"CONCLUSIONS:":[228],"Given":[229],"levels":[232],"BPH":[234],"treatment,":[236],"overall":[237],"over":[245],"alpha-blockers.":[246],"In":[247],"interests":[249],"shared":[251],"decision":[252],"making":[253],"it":[254],"is":[255],"consider":[258],"eliciting":[262],"preferences":[264],"patients":[266],"BPH.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2046196232","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
